Literature DB >> 16339979

Target-controlled infusion of propofol in dogs--evaluation of four targets for induction of anaesthesia.

G C Musk1, D S J Pang, T Beths, D A Flaherty.   

Abstract

Four groups of 20 dogs were anaesthetised by means of target-controlled infusions of propofol designed to achieve 2.5 microg/ml, 3.0 microg/ml, 3.5 microg/ml or 4.0 microg/ml of propofol in blood. The dogs' pulse rate and respiratory rate were recorded before premedication and induction, immediately after endotracheal intubation and three and five minutes later (times 0, 3 and 5, respectively), and their arterial blood pressure was recorded oscillometrically just before induction and at times 0, 3 and 5. The targets of 2.5, 3.0, 3.5 and 4.0 microg/ml resulted in the successful induction of anaesthesia in 13 (65 per cent), 16 (80 per cent), 20 (100 per cent) and 20 (100 per cent) of the dogs, respectively. The incidence of postinduction apnoea was 0 (0 per cent), one (5 per cent), two (10 per cent) and eight (40 per cent) at time 5 for groups 2.5, 3.0, 3.5 and 4.0 mug/ml, respectively, and its incidence at time 5 was significantly higher in the 4.0 microg/ml group (P<0.05) than in the other groups. In all the groups there was a significant (P<0.05) decrease in blood pressure between just before induction and the later measurements. Although there were no statistically significant differences between the groups in terms of inducing anaesthesia at a specific target, a target of 3.5 microg/ml appears to ensure a successful induction of anaesthesia without a significant increase in the incidence of apnoea.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339979     DOI: 10.1136/vr.157.24.766

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  7 in total

Review 1.  Partial intravenous anesthesia in cats and dogs.

Authors:  Tanya Duke
Journal:  Can Vet J       Date:  2013-03       Impact factor: 1.008

2.  Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs.

Authors:  Peter Bell; Guangping Gao; Mark E Haskins; Lili Wang; Meg Sleeper; Huan Wang; Roberto Calcedo; Luk H Vandenberghe; Shu-Jen Chen; Chick Weisse; Elanor Withnall; James M Wilson
Journal:  Hum Gene Ther       Date:  2011-04-11       Impact factor: 5.695

3.  Hemodynamic effects of target-controlled infusion of propofol alone or in combination with a constant-rate infusion of remifentanil in dogs.

Authors:  Suzane L Beier; Cláudio R S Mattoso; Antonio J A Aguiar; Pedro T G Vianna; Flavio Massone
Journal:  Can J Vet Res       Date:  2015-10       Impact factor: 1.310

4.  Multicenter clinical evaluation of a multi-dose formulation of propofol in the dog.

Authors:  Khursheed R Mama; James S Gaynor; Ralph C Harvey; Sheilah A Robertson; Robbin L Koenig; Elizabeth M Cozzi
Journal:  BMC Vet Res       Date:  2013-12-23       Impact factor: 2.741

5.  Propofol attenuates LPS-induced tumor necrosis factor-α, interleukin-6 and nitric oxide expression in canine peripheral blood mononuclear cells possibly through down-regulation of nuclear factor (NF)-κB activation.

Authors:  Zengyang Pei; Jinqiu Wang
Journal:  J Vet Med Sci       Date:  2014-10-14       Impact factor: 1.267

6.  Anaesthetic induction and recovery characteristics of a diazepam-ketamine combination compared with propofol in dogs.

Authors:  Jacques P Ferreira; T Brighton Dzikit; Gareth E Zeiler; Roxanne Buck; Bruce Nevill; Bruce Gummow; Lynette Bester
Journal:  J S Afr Vet Assoc       Date:  2015-06-01       Impact factor: 1.474

7.  Haemodynamic changes during propofol induction in dogs: new findings and approach of monitoring.

Authors:  Andrea Cattai; Roberto Rabozzi; Heidi Ferasin; Maurizio Isola; Paolo Franci
Journal:  BMC Vet Res       Date:  2018-09-12       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.